Mosquitos Genéticamente Modificados - Third World Network

210 Third World Network (2010) Genetically engineered Aedes aegyptimosquitoes: Are there risks? 13 December 2010. http://www.biosafety-info.net/file_dir/8147755984d0e21def079c.doc211 Patil P et al. (2010) Discussion on the proposed hypothetical risksin relation to open field release of a self-limiting transgenic Aedesaegypti mosquito strains to combat dengue. As. Pac. J. Mol. Biol.& Biotech., 18(2), 241-246.212 NATIONAL BIOSAFETY BOARD DECISION APPLICATION FORAPPROVAL FOR LIMITED MARK-RELEASE RECAPTURE OFAedes aegypti WILD TYPE AND Aedes aegypti GENETICALLYMODIFIED MOSQUITOES OX513A(My1). NBB REF NO: NRE(S)609-2/1/3. APPLICANT: INSTITUTE OF MEDICAL RESEARCH. DATEOF DECISION: 5 OCTOBER 2010. http://www.biosafety.nre.gov.my/country_decision/field_trial/aedes_aegypti/nbb%20decision%20%28eng%29.pdf213 House of Lords Hansard, 25 January 2012, c235W. http://www.theyworkforyou.com/wrans/?id=2012-01-25a.235.3&s=oxitec#g235.4214 http://www.mosqguide.org.uk/participants.htm215 Expert reaction to Oxitec’s GM mosquito programme to tackle denguefever, as criticised in an NGO press release. Science Media Centrepress release, 12 January 2012. http://www.sciencemediacentre.org/pages/press_releases/12-01-12_oxitec.htm216 GeneWatch UK comments on Risk Assessment report of the MalaysianGenetic Modification Advisory Committee (GMAC) for an applicationto conduct a limited Mark-Release-Recapture of Aedes aegypti (L.)wild type and OX513A strains. GeneWatch UK, January 2011. http://www.genewatch.org/uploads/f03c6d66a9b354535738483c1c3d49e4/GMAC_response_fin.pdf217 GMAC (2011) Response to Genewatch UK on the GMAC RiskAssessment Report for the Field Experiment Involving the Release ofAedes Aegypti (L.) Wild Type and OX513a (My1) Strains. http://www.biosafety.nre.gov.my/media/response/response%20to%20genewatchuk.pdf90